Celgene Corp (NASDAQ:CELG)

Monday’s Trading Day
120.02 +1.34 / +1.13%
As of Mar 30
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
118.14 -1.88 / -1.57%
 
Volume: 596.00

Today’s Trading

Previous close118.68
Today’s open119.64
Day’s range-- - --
Volume5,209,247
Average volume (3 months)5,424,387
Market cap$95.0B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.90%
Earnings growth (next 5 years)+23.49%
Revenue growth (last year)+17.89%
P/E ratio50.2
Price/Sales11.75
Price/Book14.55

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.59+1.02%
AZNAstraZeneca-0.13-0.19%
LLYEli Lilly and Co+0.29+0.39%
BMYBristol-Myers Squibb+0.50+0.77%
Data as of 03/30/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account